Fingerprint
Dive into the research topics of 'A Phase II Study of Sorafenib Combined With Cetuximab in EGFR-Expressing, KRAS-Mutated Metastatic Colorectal Cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Khanh Do, Liang Cao, Zhigang Kang, Baris Turkbey, Maria L. Lindenberg, Erin Larkins, Beata Holkova, Seth M. Steinberg, Mark Raffeld, Cody J. Peer, William D. Figg, Michelle Eugeni, Paula Jacobs, Peter Choyke, John J. Wright, James H. Doroshow, Shivaani Kummar*
Research output: Contribution to journal › Article › peer-review